Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancer
CONCLUSIONS: In patients with PDAC, detection of KRAS mutations in plasma proved independently predictive of early recurrence after surgical resection but did not correlate with PFS following chemotherapy.PMID:34632919 | DOI:10.1080/15384047.2021.1980312
Source: Cancer Biology and Therapy - Category: Cancer & Oncology Authors: Soichiro Ako Hironari Kato Kazuhiro Nouso Hideaki Kinugasa Hiroyuki Terasawa Hiroshi Matushita Saimon Takada Yosuke Saragai Sho Mizukawa Shinichiro Muro Daisuke Uchida Takeshi Tomoda Kazuyuki Matsumoto Shigeru Horiguchi Daisuke Nobuoka Ryuichi Yoshida Yuz Source Type: research
More News: Adenocarcinoma | Biology | Cancer | Cancer & Oncology | Chemotherapy | Eloxatin | Pancreas | Pancreatic Cancer | Study